ANTIAGING INSTITUTE OF CALIFORNIA where precision meets excellence. Laboratory-grade research compounds with 99%+ purity, trusted by researchers worldwide.
Unlock your potential with premium research peptides. Rigorously tested for 99% purity and consistency.
Fringilla urna porttitor rhoncus dolor purus non. Nulla malesuada pellentesque elit eget gravida cum.
Hot Discount - 15% OFF
Use your coupon code during checkout to benefit an up to 15% -20% discount on all products sitewise
Featured Products
Explore Our Current Enlisted Products
-
tirzepatide 10 mg Pen
Price range: $110.00 through $400.00Select options This product has multiple variants. The options may be chosen on the product page -
tirzepatide 2.5 mg
Price range: $75.00 through $250.00Select options This product has multiple variants. The options may be chosen on the product page -
tirzepatide 5 mg Pen
Price range: $100.00 through $350.00Select options This product has multiple variants. The options may be chosen on the product page -
tirzepatide 7.5 mg Pen
Price range: $110.00 through $400.00Select options This product has multiple variants. The options may be chosen on the product page
Zepbound Tirzepatide
-
tirzepatide 10 mg Pen
Price range: $110.00 through $400.00Select options This product has multiple variants. The options may be chosen on the product page -
tirzepatide 7.5 mg Pen
Price range: $110.00 through $400.00Select options This product has multiple variants. The options may be chosen on the product page -
tirzepatide 5 mg Pen
Price range: $100.00 through $350.00Select options This product has multiple variants. The options may be chosen on the product page -
tirzepatide 2.5 mg
Price range: $75.00 through $250.00Select options This product has multiple variants. The options may be chosen on the product page
Tirzepatide Near Me: Online Care From Licensed Clinicians
Looking for tirzepatide near me?
You may be searching for a doctor who can evaluate you, explain your options and help you understand whether tirzepatide is appropriate for you.
With telehealth, you may not need to drive to a weight loss clinic or wait for an in-person appointment. Depending on where you live and where our clinicians are licensed to practice, your medical evaluation may be completed online.
At ANTIAGING INSTITUTE OF CALIFORNIA, our goal is simple. We connect eligible patients with medical care that is focused on their health history, treatment goals and safety.
Our clinic is located on West 190th Street, Torrance, CA 90503, USA. Telehealth availability depends on clinician licensure, patient location and applicable rules.
A prescription is never guaranteed. A licensed clinician must decide whether tirzepatide is appropriate for you after reviewing your medical information.
🩺 Start with a medical evaluation
[Fill Our Availability Checker below]
[Check If you are Eligible for Tirzepatide Treatment blow]
🧬 What tirzepatide actually is
Tirzepatide is a once-weekly injectable medication. It works on two gut hormone systems at the same time, called GLP-1 and GIP. Those hormones normally show up after you eat. They tell your brain you’re full, slow down how fast your stomach empties, and help your body manage blood sugar.
Tirzepatide copies those hormones. That’s why people on it tend to feel full faster, think about food less, and eat smaller portions without white-knuckling it.
It’s sold under two brand names, made by the same company (Eli Lilly), for two different approved uses:
- Mounjaro – approved for type 2 diabetes
- Zepbound – approved for chronic weight management in adults with obesity, or overweight plus a weight-related health condition
Both contain the exact same active ingredient. The brand name just depends on why it was prescribed.
🔍 Tirzepatide at a glance
| Drug class | GLP-1 / GIP receptor agonist |
| Brand names | Zepbound (weight management), Mounjaro (type 2 diabetes) |
| How it’s taken | Injected under the skin (subcutaneous) |
| How often | Once a week |
| Approved for | Adults with obesity, or overweight with a related condition; type 2 diabetes |
| FDA approval | First approved 2022 |
🔍 What we actually prescribe (and where it comes from)
This part matters more than almost anything else on this page, so we’re not going to bury it.
We work with more than one source, depending on what’s right for you. When you’re prescribed FDA-approved Zepbound or Mounjaro, that’s the brand-name medication made by Eli Lilly, sourced through Lilly’s own channels. Nothing compounded, nothing substituted.
Some patients are prescribed compounded tirzepatide instead, dispensed through our licensed compounding pharmacy partners, Vylix Research and Pepvida. Compounded tirzepatide contains the same active ingredient as the FDA-approved brand, but it’s made by a compounding pharmacy, not by Eli Lilly. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality the way brand-name drugs are. We’ll never suggest compounded tirzepatide is “the same as” or interchangeable with the FDA-approved brand. It shares an ingredient. It is not the same product.
Either way: you’ll know exactly what’s in your prescription, who made it, and where it came from, before you pay for anything. 🙌
🤝 Why people choose to get care here
We’re not going to throw a wall of stock photos at you. Here’s what actually backs this page up:
- 🩺 Licensed physicians, named and credentialed (not stock photos, not “our medical team” with no faces attached)
- 📜 Licensed to serve patients in all 50 states
- 🔒 HIPAA-compliant telehealth platform
- 💊 Named pharmacy partners, disclosed openly (see the sourcing section below)
- 🗓️ Every medical page on this site is reviewed by a licensed clinician, and dated when it was last reviewed
If a health website can’t tell you who wrote the medical content and when it was last checked, that’s worth noticing. We tell you both, every time.
👨⚕️ Meet the physician behind the care
Dr. Ramin M. Roohipour, MD
Our medical director’s background is in general and bariatric surgery, with published clinical work spanning weight-loss surgery outcomes, gastrointestinal complications, colorectal oncology, transplant medicine, and trauma care. That range shows up in how care is approached here: careful attention to the medical fundamentals of weight management, not just prescribing and moving on.
Education & Credentials
Dr. Roohipour’s medical education began with his graduation from medical school in 1996, followed by a general surgery residency at Columbia University College of Physicians & Surgeons at Harlem Hospital Center. He expanded his expertise through a series of specialized clinical research fellowships: one year in transplant surgery at the University of Miami, a year in colorectal surgery at Cleveland Clinic Florida, and another year in colorectal oncologic surgery at Memorial Sloan-Kettering Cancer Center in New York. He then completed a clinical fellowship in Minimally Invasive, Metabolic, and Endocrine Surgery at the Icahn School of Medicine at Mount Sinai.
Dr. Roohipour is board-certified in General Surgery by the American Board of Surgery and is a Fellow of both the American College of Surgeons (FACS) and the American Society of Metabolic and Bariatric Surgeons (ASMBS). He currently serves as the Program Director of the Bariatric and Advanced GI – Minimally Invasive Surgery Fellowship at R&R Surgical Institute.
Selected publications:
- Roohipour, R., Angelo, A. “Revision of Vertical Band Gastroplasty: Avoiding Pitfalls.” Bariatric Times, 2023; 20(7-12): 30-32.
- Herron, D., Roohipour, R. “Complications of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy.” Abdominal Imaging, 2012 Oct; 37(5): 712-8.
- Herron, D., Roohipour, R. “Bariatric Operations, Anatomy and Mechanisms of Action.” Gastrointestinal Endoscopy Clinics of North America, 2011; 21: 213-228.
- Roohipour, R., Patil, S., Goodman, K.A., et al. “Squamous Cell Carcinoma of the Anal Canal: Predictors of Treatment Outcome.” Diseases of the Colon and Rectum, 2008 Feb; 51(2): 147-53.
- Talus, H., Roohipour, R., Depaz, H., Adu, A.K. “Preduodenal Portal Vein Causing Duodenal Obstruction in an Adult Patient.” Journal of the American College of Surgeons, 2006 Mar; 202(3): 552-3.
- Ciancio, G., Burke, G.W., Gaynor, J.J., et al. “The Use of Campath-1H as Induction Therapy in Renal Transplantation: Preliminary Results.” Transplantation, 2004 Aug; 78(3): 426-433.
- Roohipour, R., Varasteh Kia, G.R., Tehrani, A., Moradi, M. “Comparison of Two Methods of Bowel Preparation.” 2002 Nov; 9(30): 349-356.
- Roohipour, R., Varasteh Kia, G.R., Tehrani, A., Moradi, M. “Comparison of Accuracy of Trauma Scoring System for Prediction of Patients’ Prognosis.” Journal of Iran University of Medical Sciences, 2002 May; 9(28): 129-138.
Is Tirzepatide Telehealth Available in My State?
One of the most common questions behind a search for “tirzepatide near me” is simple:
Can I actually receive care where I live?
The answer depends on your location.
Telehealth does not remove licensing requirements. In California, for example, the Medical Board of California says physicians providing telehealth to patients located in California must have a valid California medical license, and the standard of care is the same for telehealth and in-person care.
That means the important question is not only how close a clinic is to your home.
It’s also:
- Is the clinician licensed where you are?
- Does the clinic offer telehealth in your state?
- Is an online medical evaluation available?
- Can the clinician legally prescribe the medication for your situation?
- How will your prescription be fulfilled?
📍 Your location matters
Patient location → Clinician licensure → Medical evaluation → Treatment decision
That’s why our availability checker above is designed to include your state where we will check if we are licensed in your to serve in your state and get back to you.
[Enter Your State]
✅ Telehealth available
✅ Licensed clinician available
✅ Medical evaluation required
✅ Prescription only when medically appropriate
Availability can change. Always confirm current availability before scheduling.
Get Tirzepatide Care From Home
Searching for tirzepatide near me does not always mean you need a physical clinic nearby.
Telehealth can allow you to complete parts of your care from home.
A typical process may include an online intake, a clinician review, a medical consultation and ongoing follow-up.
🏠 What this can look like
Step 1: Complete your health history
Step 2: Meet with a licensed clinician
Step 3: Discuss treatment options
Step 4: Receive a prescription only if appropriate
Step 5: Follow your treatment plan
Step 6: Attend follow-up visits as directed
The exact process may vary based on your medical history and the clinician’s judgment.
Our clinicians may ask about:
- Your current weight and height
- Your medical history
- Current medications
- Allergies
- Previous weight-management treatments
- Other health conditions
- Pregnancy or plans for pregnancy, when relevant
- Symptoms and treatment goals
- Relevant laboratory results, if needed
This helps the clinician decide whether tirzepatide is appropriate and whether additional evaluation is needed.
🧠 How tirzepatide works in your body
Here’s the plain-English version, no biochemistry degree needed.
After you eat, your gut naturally releases hormones that tell your brain “okay, that’s enough.” Those same hormones slow down digestion a bit and help your body handle the sugar from your meal. In people who struggle with weight or blood sugar, that signal can be weaker than it should be.
Tirzepatide acts like a stand-in for those hormones. Once a week, it:
- 🍽️ Helps you feel full sooner and stay full longer
- 🐢 Slows down how fast food leaves your stomach
- 🩸 Helps your body respond better to insulin
None of this works by magic on its own. It works alongside a lower-calorie diet and regular movement, which is why it’s approved as part of a broader plan, not a standalone fix.
✅ Who tirzepatide is typically for
This isn’t a full medical screening (that’s what your consultation is for), but here’s a general sense of who tends to qualify, and who usually doesn’t.
✅ Often a fit if you:
- Have a BMI of 30 or higher, OR
- Have a BMI of 27 or higher, plus a weight-related condition like high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea
- Are an adult
- Aren’t pregnant, trying to become pregnant, or breastfeeding
- Have no personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
🚫 Usually not a fit if you:
- Have a personal or family history of medullary thyroid cancer (MTC)
- Have MEN 2
- Are pregnant, trying to conceive, or breastfeeding
- Have had a serious allergic reaction to tirzepatide before
- Have a history of pancreatitis (this needs a direct conversation with your provider, not a blanket yes or no)
This list isn’t complete, and it’s not a diagnosis. Your provider reviews your full health history, current medications, and labs before deciding if tirzepatide is right for you. 📋
💉 How to use tirzepatide: step by step
This section walks through how tirzepatide is generally used. Your prescribing provider sets your actual starting dose, schedule, and any changes. This is general education, not personal medical instructions.
The basics
- 💉 It’s injected just under the skin (subcutaneous), using a prefilled pen
- 📍 Common injection spots: stomach (abdomen), front of the thigh, or back of the upper arm
- 🔄 Rotate the spot each week, don’t use the exact same spot twice in a row
- 📅 It’s a once-a-week shot, and picking the same day each week makes it easier to remember
The typical starting schedule (FDA framework)
Tirzepatide dosing usually starts low and increases slowly. This is the general framework used in the FDA-approved labeling for tirzepatide. Your own plan may look different depending on how you respond.
| Step | Dose | Timing |
|---|---|---|
| 1 | 2.5 mg once weekly | First 4 weeks (this dose gets your body used to it, it’s not meant to be a long-term maintenance dose) |
| 2 | 5 mg once weekly | After at least 4 weeks, if approved by your provider |
| 3 | Up by 2.5 mg | Every 4 weeks or longer, based on how you’re doing |
| 4 | Maintenance dose | Usually settles at 5 mg, 10 mg, or 15 mg once weekly |
Some people stay at a lower maintenance dose if that’s what their body tolerates well. That’s normal, and it’s a conversation to have with your provider, not something to decide on your own.
If you miss a dose
If you miss your weekly dose, the general guidance is to take it as soon as you remember, as long as it’s within 4 days (96 hours) of when it was due. If more than 4 days have passed, skip that dose and take your next one on your regular scheduled day. If you’re ever unsure, check with your care team before doubling up or guessing.
📦 Quick-glance: your weekly routine
1️⃣ Pick your day, same day every week
2️⃣ Pick your spot, stomach, thigh, or upper arm (rotate weekly)
3️⃣ Check the pen, no cloudiness, no particles, not expired
4️⃣ Inject, hold a few seconds, done
5️⃣ Log it, symptoms, weight, how you're feeling, for your next check-in🧊 Storing your medication
- Keep it in the refrigerator between uses
- Don’t freeze it, and don’t use it if it has been frozen
- It can be kept at room temperature for a limited window before use, check the specific instructions that come with your prescription
- Keep it away from direct light and heat
- Before each injection, look at it. If it’s cloudy, discolored, or has particles floating in it, don’t use it, call your pharmacy instead
- Used needles go in a proper sharps container, never in the regular trash
Zepbound, Mounjaro and Tirzepatide: What’s the Difference?
These names are often used together online, which can make things confusing.
Tirzepatide
Tirzepatide is the active drug ingredient.
Zepbound
Zepbound is a brand-name tirzepatide product.
The FDA approved Zepbound for chronic weight management in adults with obesity or adults with overweight plus at least one weight-related condition in 2023. The FDA later approved Zepbound for moderate to severe obstructive sleep apnea in adults with obesity.
Mounjaro
Mounjaro is another brand that contains tirzepatide, with an FDA-approved indication for improving blood sugar in adults with type 2 diabetes mellitus.
💡 Simple comparison
Tirzepatide = active ingredient
Zepbound = brand-name tirzepatide product
Mounjaro = another brand-name tirzepatide product
A clinician should determine which treatment is appropriate for your medical situation.
And patients should not assume that every product marketed as “tirzepatide” has the same approval status, labeling or regulatory pathway.
Who May Be a Candidate for Tirzepatide?
Tirzepatide is not right for everyone.
For FDA-approved Zepbound’s weight-management indication, the FDA describes use in adults with obesity or adults with overweight who have at least one weight-related condition, together with a reduced-calorie diet and increased physical activity.
But meeting a BMI number alone does not replace medical evaluation.
Your clinician may consider:
- Your BMI and weight history
- Your medical conditions
- Your medications
- Your allergies
- Your previous treatment experience
- Your symptoms
- Your treatment goals
- Your pregnancy status, when relevant
- Potential contraindications or safety concerns
- Whether additional testing is needed
🩺 Medical care comes first
An online quiz should not be treated as a medical diagnosis.
And completing a questionnaire should not be treated as an automatic prescription.
A clinician must make the treatment decision.
🏥 Our pharmacy and sourcing partners
We work with the following sources. Here’s what each one is, plainly stated:
- zepbound.lilly.com – Eli Lilly’s own site for Zepbound, the FDA-approved brand-name tirzepatide. This is the manufacturer directly.
- vylixresearchs.com – A licensed compounding pharmacy that prepares compounded tirzepatide under a valid prescription.
- pepvida.com – A licensed compounding pharmacy that prepares compounded tirzepatide under a valid prescription.
[Since our above sources are 503B licensed pharmacies especially ZEPBOUND, we are legally allowed to compound and ship across state lines]
We take sourcing disclosure seriously. If any medication you receive isn’t the FDA-approved brand, we’ll tell you plainly, before you pay for anything, not in fine print you have to go looking for.
⚠️ Safety and possible side effects (for patients)
Common side effects (usually mild, often ease up over time):
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Stomach pain or indigestion
- Lower appetite
- Redness or irritation at the injection site
Serious risks to know about:
🚨 Thyroid tumor warning. Tirzepatide carries an FDA boxed warning, the strongest warning the FDA issues. In rat studies, tirzepatide caused thyroid C-cell tumors. It’s not known whether this happens in humans. Because of this, tirzepatide should not be used by anyone with a personal or family history of medullary thyroid cancer, or a condition called MEN 2. Tell your provider right away if you notice a lump in your neck, trouble swallowing, shortness of breath, or a hoarse voice that doesn’t go away.
Other things to watch for and report to your provider:
- Severe or ongoing stomach pain (can be a sign of pancreatitis or gallbladder trouble)
- Signs of dehydration paired with kidney issues (very low urine output, dizziness, extreme thirst)
- Signs of a serious allergic reaction (swelling of the face or throat, trouble breathing, hives)
- Low blood sugar symptoms, especially if you’re also on insulin or certain diabetes medications
- Vision changes, especially if you have diabetic eye disease
This is general information, not a full list, and not personal medical advice. If you’re having a medical emergency, call 911 or your local emergency number right away. 🚑
🩺 Safety information for healthcare providers
This section is written for prescribers, referring clinicians, and other healthcare professionals reviewing this page. It summarizes key label points, it does not replace the full FDA prescribing information, which should be reviewed before initiating therapy.
Boxed warning: Tirzepatide caused dose-dependent and treatment-duration-dependent thyroid C-cell tumors in rat studies. Human relevance has not been established. Tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients on early symptoms of thyroid tumors (neck mass, dysphagia, dyspnea, persistent hoarseness). Routine calcitonin monitoring or thyroid ultrasound is of uncertain value for early detection in this setting.
Contraindications:
- Known hypersensitivity to tirzepatide or any excipient
- Personal or family history of MTC
- MEN 2
Drug interactions and clinical considerations:
- Tirzepatide delays gastric emptying and may affect absorption of concomitant oral medications. Monitor accordingly, particularly for narrow-therapeutic-index drugs.
- Advise patients using oral contraceptives to switch to a non-oral method, or add a barrier method, for 4 weeks after initiation and for 4 weeks after each dose increase.
- Concurrent use with insulin or insulin secretagogues (e.g., sulfonylureas) increases hypoglycemia risk. Consider a dose reduction of the concomitant agent.
- Rapid improvement in glycemic control has been associated with temporary worsening of diabetic retinopathy. Monitor patients with a history of diabetic retinopathy.
Additional warnings and monitoring points:
- Severe gastrointestinal adverse reactions
- Acute kidney injury secondary to volume depletion (from vomiting, diarrhea, or reduced intake)
- Acute gallbladder disease
- Acute pancreatitis, discontinue promptly if suspected and confirmed
- Hypersensitivity reactions reported postmarketing
- Pens are single-patient use only and should never be shared between patients, even with a needle change
Use in specific populations:
- Pregnancy: may cause fetal harm based on animal data; discontinue if pregnancy occurs
- Not established for use in pregnancy or lactation
- Renal and hepatic impairment: review current label guidance, as dose adjustment recommendations may apply
We encourage all prescribers to consult the complete, current FDA prescribing information before starting a patient on tirzepatide, and to report suspected adverse events to FDA MedWatch.
How Our Tirzepatide Telehealth Program Works
Getting started should feel clear.
Here’s the process.
1. Complete your medical intake 📝
You’ll provide information about your health, medications, medical conditions and treatment goals.
Please be accurate.
Your clinician uses the information you provide as part of the medical evaluation.
2. Meet with a licensed clinician 🩺
The clinician reviews your health information and discusses your goals.
You should have the opportunity to ask questions.
3. Receive a treatment decision 📋
If tirzepatide is appropriate, the clinician may prescribe it.
If it’s not appropriate, the clinician may recommend another option or additional evaluation.
4. Follow your treatment plan 💊
If medication is prescribed, use it exactly as directed.
Your treatment plan may include nutrition, physical activity and follow-up visits.
5. Continue monitoring 🔄
Follow-up care matters.
Your clinician may review how you are responding, ask about side effects and decide whether your treatment needs to change.
What Happens During a Tirzepatide Telehealth Consultation?
Many people worry about what will happen during an online medical visit.
The consultation is a medical appointment.
It is not supposed to be a sales call.
Your clinician may ask about your:
Health history
Weight history
Current medications
Allergies
Other medical conditions
Previous weight-management efforts
Treatment goals
Relevant symptoms
Pregnancy status when applicable
You may also be asked to provide recent measurements or medical records.
And depending on your history, a clinician may decide that additional testing or an in-person evaluation is needed.
Questions you can ask
Don’t be afraid to ask:
“Why are you recommending this medicine?”
“What are the main risks for me?”
“What should I do if I have side effects?”
“What happens if this medicine isn’t right for me?”
“How should I take the medication?”
“What happens at my follow-up visit?”
Good medical care includes clear communication.
How to Use Tirzepatide
Detailed patient guide for FDA-approved Zepbound
The instructions below apply to FDA-approved Zepbound and are based on the current FDA prescribing information and Lilly’s patient instructions. Always follow the exact instructions for the product and presentation you were prescribed.
💉 How often is Zepbound taken?
Zepbound is taken once a week.
It can be taken at any time of day, with or without food.
📅 Where is it injected?
For the approved Zepbound presentations, the medication is injected under the skin.
Common sites include:
- Abdomen
- Thigh
- Back of the upper arm when another person gives the injection
Rotate the injection site with each dose. Do not inject into a muscle or vein.
🧪 What dose do people start with?
The current FDA prescribing information lists 2.5 mg once weekly for 4 weeks as the recommended starting dosage.
The 2.5 mg dose is a starting dose and is not an approved maintenance dose.
After at least four weeks, the dose may be increased in 2.5 mg steps, based on treatment response and tolerability.
For weight reduction and long-term maintenance, the FDA lists recommended maintenance doses of 5 mg, 10 mg or 15 mg once weekly.
The maximum recommended dose is 15 mg once weekly.
📈 Simple dosing infographic
START
2.5 mg once weekly
│
│ after at least 4 weeks
▼
5 mg once weekly
│
│ if clinically appropriate
▼
7.5 mg
│
│ if clinically appropriate
▼
10 mg
│
│ if clinically appropriate
▼
12.5 mg
│
│ if clinically appropriate
▼
15 mg maximum recommended doseNot everyone should move through every dose.
Your clinician should decide the dose based on your response and tolerability.
⏰ What if you miss a dose?
The current FDA label says that if a dose is missed, it should be taken as soon as possible within 4 days, or 96 hours.
If more than 4 days have passed, the missed dose should be skipped and the next dose taken on the regular day.
The next weekly dose should then continue on the normal schedule.
🔁 Can I change my weekly injection day?
The FDA label says the weekly administration day may be changed when needed, provided there are at least 72 hours between doses.
👀 What should the medicine look like?
The current FDA information describes Zepbound as a clear, colorless to slightly yellow solution.
Do not use it if you see particles or unexpected discoloration.
🚫 Don’t share injection devices
Do not share a Zepbound KwikPen between patients, even if the needle is changed.
The FDA added this warning to the current prescribing information.
⚠️ Important point about compounded products
Do not take dosing instructions from a random website, social media post or online comment.
Compounded products may use different concentrations, packaging and instructions.
Patients should follow the prescription label and the specific instructions provided by the prescribing clinician and dispensing pharmacy.
Do not convert a compounded product’s “units” into milligrams unless your prescribing clinician or pharmacist has given you the exact instructions for that product.
Word Infographic: Your Weekly Tirzepatide Routine
📅 SAME DAY EACH WEEK
1️⃣ Check your scheduled dose
↓
2️⃣ Read your prescription instructions
↓
3️⃣ Check the medication
↓
4️⃣ Wash your hands
↓
5️⃣ Prepare the prescribed device
↓
6️⃣ Choose the injection site
↓
7️⃣ Inject under the skin as instructed
↓
8️⃣ Dispose of needles safely, if applicable
↓
9️⃣ Record the dose if your care plan recommends it
↓
🔟 Continue normal follow-upYour own prescription instructions always take priority.
Branded Tirzepatide vs Compounded Tirzepatide
This is an area where patients need clear information.
What is an FDA-approved product?
An FDA-approved drug has gone through the FDA drug approval process for its approved use.
Zepbound is an FDA-approved tirzepatide product.
What is a compounded drug?
Compounded drugs are prepared under a different regulatory framework.
They are not FDA-approved, and FDA says compounded drugs are not reviewed by the agency for safety, effectiveness or quality before marketing in the same way as FDA-approved drugs.
That distinction should be clear on any patient-facing website.
⚠️ Why this matters
In 2026, FDA issued multiple warning letters to telehealth companies over misleading marketing of compounded GLP-1 products, including tirzepatide.
FDA specifically warned companies not to imply that compounded products are FDA-approved, that they are the same as approved products, or that a compounding pharmacy is “FDA-approved” or “FDA-licensed.”
So our website should never say:
“Our compounded tirzepatide is the same as Zepbound.”
And it should not say:
“FDA-approved compounded tirzepatide.”
Those statements can create a misleading impression about a product’s regulatory status.
🧾 What patients should know
Before accepting any compounded medication, ask:
Who compounded it?
What pharmacy dispensed it?
What does the pharmacy label say?
What concentration is it?
What is the exact dose?
How should it be stored?
How should it be used?
What should I do if I have a problem?
The clinician and dispensing pharmacy should be able to provide clear answers.
Tirzepatide Safety, Side Effects and Important Warnings
Tirzepatide is a prescription medicine.
It should be taken as directed by your healthcare provider.
The current FDA prescribing information includes important warnings and precautions.
⚠️ Thyroid tumor warning
The FDA prescribing information has a boxed warning about the risk of thyroid C-cell tumors seen in rats.
It is not known whether Zepbound causes these tumors in humans.
Zepbound is contraindicated in people with a personal or family history of medullary thyroid carcinoma, or MTC, and in people with Multiple Endocrine Neoplasia syndrome type 2, or MEN 2.
Tell your healthcare provider about any relevant personal or family history.
Seek medical advice if you develop symptoms such as a neck mass, trouble swallowing, trouble breathing or persistent hoarseness.
🤢 Gastrointestinal side effects
Common side effects include:
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Abdominal pain
- Indigestion
- Belching
- Heartburn
The FDA label also lists injection-site reactions, fatigue, hair loss and hypersensitivity reactions among reported adverse reactions.
Some gastrointestinal reactions can be severe.
The FDA says Zepbound is not recommended in patients with severe gastroparesis.
💧 Dehydration and kidney problems
Vomiting and diarrhea can cause fluid loss.
The FDA label warns about acute kidney injury due to volume depletion and says renal function should be monitored in patients who report adverse reactions that may cause volume depletion.
🟡 Gallbladder problems
Acute gallbladder disease has been reported in clinical trials.
If a clinician suspects cholecystitis, evaluation and follow-up are appropriate.
🔥 Pancreatitis
Acute pancreatitis has been observed in patients treated with GLP-1 receptor agonists and Zepbound.
The FDA says to discontinue Zepbound if pancreatitis is suspected.
Severe or persistent abdominal pain needs medical attention.
🚨 Serious allergic reactions
Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported after tirzepatide.
If a serious allergic reaction is suspected, prompt medical attention is needed.
🩸 Low blood sugar
The risk of hypoglycemia can increase when Zepbound is used with insulin or an insulin secretagogue such as a sulfonylurea.
Your clinician may need to adjust other diabetes medicines.
👁️ Diabetic retinopathy
The current label advises monitoring patients with a history of diabetic retinopathy for progression.
🧠 Mood and behavior changes
The current FDA label includes a warning to monitor for depression, suicidal thoughts or unusual changes in mood or behavior.
Patients with a history of suicide attempts or active suicidal ideation should not use Zepbound according to the current label.
🏥 Surgery and anesthesia
Tell your healthcare team that you are taking Zepbound before surgery or procedures requiring general anesthesia or deep sedation.
The FDA label notes reports of pulmonary aspiration in patients taking GLP-1 receptor agonists during such procedures.
🤰 Pregnancy
Weight loss offers no benefit during pregnancy and may cause fetal harm.
The current FDA label says to discontinue Zepbound when pregnancy is recognized.
Patients who are pregnant, planning pregnancy or who may become pregnant should discuss this with their healthcare provider.
The label also contains specific guidance for people using oral hormonal contraceptives because tirzepatide can affect absorption of oral medications.
How Effective Is Tirzepatide?
Medication response varies from person to person.
Clinical trials of Zepbound showed greater weight reduction compared with placebo when used together with a reduced-calorie diet and increased physical activity.
In the FDA-reviewed 72-week trials, the study measured both average percent change in body weight and the percentage of participants reaching at least 5% weight reduction. Higher percentages of patients in the Zepbound groups reached larger weight-loss thresholds compared with placebo.
For example, in one major trial, the FDA label reports that at week 72, 90.9% of participants receiving 15 mg reached at least 5% weight reduction, compared with 34.5% receiving placebo. In that same study, 83.5% of the 15 mg group reached at least 10% weight reduction, compared with 18.8% in the placebo group.
These are study results.
They are not a promise of what any individual patient will experience.
Your response can be different.
💰 What it costs
[EDITOR: replace the placeholders below with your real numbers before publishing.]
| Item | Typical range | Notes |
|---|---|---|
| Initial consultation | [$195 usd] | Includes provider review and eligibility check |
| Monthly medication (with insurance) | [$25 usd] | Depends on coverage and prior authorization |
| Monthly medication (without insurance) | [$550 usd] | Varies by dose and whether it’s brand or compounded |
| Follow-up visits | [$150 usd] | [frequency: monthly] |
A few honest notes on cost, since this is one of the biggest questions people have:
- Insurance coverage for weight-loss medications varies a lot by plan, and many plans require prior authorization
- Eli Lilly offers a manufacturer savings card for eligible patients with commercial insurance for Zepbound, worth checking directly at zepbound.lilly.com
- If a price online seems dramatically lower than everywhere else, ask exactly what you’re being sold, brand name or compounded, and from where
🌎 Where we currently see patients
As a telehealth clinic, we currently see patients in all 50 states. Because prescribers must be licensed in the state where a patient is physically located at the time of the visit, our provider network is licensed nationwide so coverage isn’t limited by where you live. Check our available in-person store locations above
❓ Frequently asked questions
Is compounded tirzepatide the same as Zepbound or Mounjaro? No. Compounded tirzepatide contains the same active ingredient, but it’s made by a compounding pharmacy, not by Eli Lilly, and it isn’t FDA-reviewed for safety, effectiveness, or quality the way the brand-name product is.
How much does tirzepatide cost without insurance? It varies by dose and by whether you’re getting the brand-name product or a compounded version. [OUR PRICE RANGE VARIES FROM $150 usd for online consultations to $1500 usd monthly follow up checkes.]
Do I need a type 2 diabetes diagnosis to get tirzepatide? No. Zepbound is approved for weight management in adults with obesity, or overweight plus a weight-related condition, without requiring a diabetes diagnosis. Mounjaro is the version approved specifically for type 2 diabetes.
What states do you serve? All 50 states. We’re a telehealth clinic, and our provider network is licensed nationwide.
What are the most common side effects? Nausea, diarrhea, vomiting, constipation, and stomach discomfort are the most common. Most people find these ease up over the first few weeks.
How fast can I start? [You can start anytime. Fill our availability check form above]
Can I take tirzepatide with my other medications? Possibly, but it depends on what you’re taking. Tirzepatide slows digestion, which can affect how other oral medications are absorbed, including birth control pills. Tell your provider about everything you’re currently taking so they can check for interactions.
What if I miss a dose? Take it within 4 days of when it was due. If more than 4 days have passed, skip it and take your next dose on your regular schedule. Check with your provider if you’re not sure.
Is getting tirzepatide through telehealth actually safe? It can be, when the provider is properly licensed in your state, when you’re honestly screened for eligibility, and when you’re told plainly what you’re being prescribed and where it comes from. That transparency is exactly what we’ve tried to build into every section of this page.
Do you accept insurance? [Yes, we accept insurance payments for in-clinic treatments]
Where can I get tirzepatide near me?
You may be able to get tirzepatide care through a primary care clinician, weight-management clinic, specialist or telehealth provider.
For telehealth, availability depends on where you are located and where the clinician is licensed to practice.
Can I get tirzepatide online?
Telehealth may allow an eligible patient to be medically evaluated online. A prescription is not automatic. A licensed clinician must determine whether treatment is appropriate.
Can a telehealth doctor prescribe tirzepatide?
A properly licensed clinician may prescribe medications through telehealth when clinically appropriate and when applicable federal and state requirements are met.
Do I have to live near the clinic?
Not always.
With telehealth, geographic proximity to a physical office may be less important than whether the provider is licensed and authorized to care for patients in your state.
Is Zepbound the same as tirzepatide?
Zepbound contains tirzepatide.
“Tirzepatide” refers to the active drug ingredient, while Zepbound is a brand-name product containing that ingredient.
Is Mounjaro the same as tirzepatide?
Mounjaro contains tirzepatide.
The approved indications and labeling depend on the specific product.
Is compounded tirzepatide FDA-approved?
No.
FDA says compounded drugs are not FDA-approved and are not reviewed by the agency for safety, effectiveness or quality before marketing in the same way as FDA-approved drugs.
Can compounded tirzepatide be described as the same as Zepbound?
Do not assume that.
FDA has warned telehealth companies against marketing compounded GLP-1 products in ways that imply they are the same as FDA-approved products.
How often do I take Zepbound?
The current FDA prescribing information recommends once-weekly administration.
What is the starting dose?
The recommended starting dose for Zepbound is 2.5 mg once weekly for four weeks. The 2.5 mg dose is for treatment initiation and is not an approved maintenance dose.
What happens if I miss a dose?
The current FDA label says to take the missed dose within four days, or 96 hours, when possible. If more than four days have passed, skip the missed dose and take the next scheduled dose.
What are the most common side effects?
Common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain and indigestion. Other listed reactions include injection-site reactions, fatigue, hair loss, belching, heartburn and hypersensitivity reactions.
Can I use tirzepatide if I’m pregnant?
Weight loss treatment should not be used during pregnancy. The current FDA label advises discontinuing Zepbound when pregnancy is recognized.
Can I take tirzepatide with another GLP-1 medication?
The current FDA label says coadministration with other tirzepatide-containing products or any GLP-1 receptor agonist is not recommended.
What if the clinician decides tirzepatide is not right for me?
That is part of responsible medical care.
The clinician may recommend another treatment, additional testing, or follow-up with another healthcare professional.
A medical consultation is not a guarantee of a prescription.
Medical Sources and References
Primary sources
U.S. Food and Drug Administration, Zepbound prescribing information
Current FDA label, revised January 2026.
FDA, Zepbound chronic weight-management approval
FDA announcement describing the 2023 approval and approved population.
FDA, Zepbound obstructive sleep apnea approval
FDA announcement describing the OSA indication in adults with obesity.
Eli Lilly, official Zepbound patient information
Official information on use, dosage forms and administration.
Medical Board of California, Telehealth
California telehealth licensing and standard-of-care information.
FDA, Compounded GLP-1 guidance
FDA information on marketing and regulatory distinctions involving compounded GLP-1 drugs.
Why Medical Review Matters
Medical content should not be treated like ordinary blog content.
A post about a restaurant can be wrong and create an inconvenience.
A page about prescription medication can affect a person’s health.
That’s why this page should have:
A named medical reviewer
A publication date
A medical review date
Updated FDA references
Clear product distinctions
Accurate safety information
Transparent sourcing
Accurate clinician credentials
Recommended footer
Medically reviewed by Ramin M. Roohipour, MD
Specialist and Clinician
Last reviewed: [September, 2026]
Next review: [August, 2028]
Your Tirzepatide Care Starts With a Conversation
Searching for tirzepatide near me is often the first step.
The next step should be understanding whether treatment is appropriate for you.
At [Clinic Name], the focus is on medical evaluation, clear information and ongoing care.
You don’t need to guess what the medication is.
You don’t need to guess how the treatment works.
And you shouldn’t have to guess who is making the medical decision.
🩺 Ready to learn more?
[Start Your Medical Evaluation]
[Check Telehealth Availability]
⚠️ Important Safety and Medical Disclaimer
MEDICAL DISCLAIMER
The information on this page is for educational purposes only. It is not a substitute for medical advice, diagnosis or treatment from a licensed healthcare professional.
Tirzepatide is a prescription medication. A prescription should be issued only after an appropriate medical evaluation and when a clinician determines that treatment is medically appropriate.
This page does not guarantee that a patient will qualify for treatment, receive a prescription, achieve a specific amount of weight loss or experience any particular result.
Medication availability, prescribing practices, pharmacy fulfillment and telehealth eligibility may vary by state and may change over time.
Patients should use prescription medications exactly as directed by their healthcare provider and dispensing pharmacy. Do not change your dose, combine medications, or use a different formulation based on information found online.
Seek urgent medical attention for severe or concerning symptoms. For medical emergencies, call 911 or go to the nearest emergency department.
The information on this page may not include all possible risks, side effects, contraindications or drug interactions. Patients should review the current prescribing information for their medication and speak with a licensed healthcare professional about their individual circumstances.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality before marketing in the same way it reviews FDA-approved drugs. Patients should receive clear information about the identity of the medication, its source and the pharmacy that dispenses it.
Last medically reviewed: September, 10 2026
Last updated: September, 20 2026
Medical reviewer: Ramin M. Roohipour, MD
